Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

Acacia Pharma Terug naar discussie overzicht

Lancering Barhemsys H1 19 ?

3.795 Posts
Pagina: «« 1 ... 18 19 20 21 22 ... 190 »» | Laatste | Omlaag ↓
  1. [verwijderd] 8 januari 2019 17:22
    quote:

    For a fistful of dollars schreef op 8 januari 2019 16:43:

    What is the influence of next week's vote (15th of January) on the Brexit for Acacia Pharma, being registered in England ? If we move towards a no deal Brexit, then all shares of GB listed companies may head downwards...
    It seems you only post when we go down. And everytime these vague kinds of negative messages. But if shorting is your way, thats fine. But placing non relevant stupid messages here to get your profit is not.

    So why is this a stupid remark?

    Acacia only targets the.... drumroll....US market.
  2. Derwing 8 januari 2019 17:41
    quote:

    Madebeliefje schreef op 8 januari 2019 17:22:

    [...]
    It seems you only post when we go down. And everytime these vague kinds of negative messages. But if shorting is your way, thats fine. But placing non relevant stupid messages here to get your profit is not.

    So why is this a stupid remark?

    Acacia only targets the.... drumroll....US market.
    Yes I dont think Acacia should get much trouble for that. The US government shutdown on FDA approvals did cross my mind for a second though. But current applications should be uneffected by the shutdown.
  3. [verwijderd] 8 januari 2019 21:15
    quote:

    For a fistful of dollars schreef op 8 januari 2019 16:43:

    What is the influence of next week's vote (15th of January) on the Brexit for Acacia Pharma, being registered in England ? If we move towards a no deal Brexit, then all shares of GB listed companies may head downwards...
    It would not be logical or reasonable for the Brexit vote (on 15 January) to have any effect on the stock price of Acacia Pharma. The Brexit vote has nothing to do with the quality of the product and pipeline of Acacia Pharma. What is important for Acacia Pharma is the awaited FDA decision. It is possible that somebody might use the Brexit vote to manipulate price movement in the stock market. But I don't think that it will have any long lasting effect on Acacia Pharma. I have not been able to find any news in the public domain that can explain the present low value of the stock price of Acacia Pharma. If people are selling the stock because of the upcoming Brexit vote, then I think that such line of action is unreasonable. The FDA decision can come any day from now--very unexpectedly. So, one has to be careful.
  4. Derwing 8 januari 2019 21:51
    quote:

    Investor68 schreef op 8 januari 2019 21:15:

    [...]

    It would not be logical or reasonable for the Brexit vote (on 15 January) to have any effect on the stock price of Acacia Pharma. The Brexit vote has nothing to do with the quality of the product and pipeline of Acacia Pharma. What is important for Acacia Pharma is the awaited FDA decision. It is possible that somebody might use the Brexit vote to manipulate price movement in the stock market. But I don't think that it will have any long lasting effect on Acacia Pharma. I have not been able to find any news in the public domain that can explain the present low value of the stock price of Acacia Pharma. If people are selling the stock because of the upcoming Brexit vote, then I think that such line of action is unreasonable. The FDA decision can come any day from now--very unexpectedly. So, one has to be careful.
    I think most investors already assume that the FDA will aprove Barhemsys. In that sense, an approval on the 5th of may or before should not increase the stock price either. Yet it will, just like a mere delay in the approval caused the stock to drop by 70%. For barely any stock nowadays does the value truely represent the intrinsic company value. Stocks that pay out dividends are typically getting close, as nobody can argue with the hard cash it pays off. But all stocks are somehow effected by factors that should have absolutely no effect on the company.

    As for Acacia Pharma, the expected year at which it will assume to make profit is 2022/2023. Athough it is a few more years from now, it is within a reasonable timeframe. If you believe in the company and the product then it doesn't matter what happens to the Brexit, the trade war or the delayed FDA approval. After 2023, the Acacia stock price will be based on the money they are making.
  5. Derwing 9 januari 2019 08:05
    Voorbeurs een kooporder van 130 aandelen tegen de marktprijs. Manipulatie naar boven toe? Voor nog geen 200 euro aandelen kopen, dan mag je wel een verdomd goedkope broker hebben wil het zin hebben qua transactiekosten.
  6. Derwing 16 januari 2019 08:14
    Vanwege de brexit?
    Vooralsnog lijkt het erop dat we gaan openen rond 1.6, maar wel kans dat we verder gaan wegzakken komende weken. We liggen gewoon weer ongeveer op de dalenende trendlijn die al sinds de IPO is ingezet (als je de pieken en dalen eruit haalt gaat je lijn linear een klein beetje naar beneden).
  7. [verwijderd] 16 januari 2019 21:18
    Voorlopig heeft de Brexit niet echt een negatieve invloed op de koers. Nu May de stemming heeft overleeft hoop ik op een stabiel koerspatroon tussen 1.5 en 1.7.
  8. Derwing 17 januari 2019 07:52
    Ik had eergister 12,5% van mijn aandelen verkocht, met het plan die rond 1.4 weer terug te kopen. Helaas staat er nu 13.000 bestens in de bied...mooie timing weer. We gaan vandaag richting de 1.7 in ieder geval. Ben benieuwd of dit weer een tijdelijke opleving is, of dat het tij nu aan het keren is.
  9. Wil Helmus 17 januari 2019 08:45
    Laten we hopen op het laatste. Bestens orders van 13.000 stuks lijkt mij een goed teken. Maar aan de andere kant, 5 mei is nog ver weg. Het kan nog alle kanten op.
3.795 Posts
Pagina: «« 1 ... 18 19 20 21 22 ... 190 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 465 6.840
AB InBev 2 5.286
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.580 46.448
ABO-Group 1 19
Acacia Pharma 9 24.692
Accell Group 151 4.129
Accentis 2 253
Accsys Technologies 22 8.936
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 160
ADMA Biologics 1 31
Adomos 1 126
AdUX 2 457
Adyen 13 16.461
Aedifica 2 832
Aegon 3.257 320.084
AFC Ajax 537 7.018
Affimed NV 2 5.761
ageas 5.843 109.778
Agfa-Gevaert 13 1.862
Ahold 3.536 73.983
Air France - KLM 1.024 34.348
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 466 12.774
Alfen 12 16.505
Allfunds Group 3 1.216
Almunda Professionals (vh Novisource) 651 4.247
Alpha Pro Tech 1 17
Alphabet Inc. 1 337
Altice 106 51.196
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.485 114.765
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.821 240.349
AMG 965 125.826
AMS 3 73
Amsterdam Commodities 303 6.522
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 382
Antonov 22.632 153.605
Aperam 91 14.155
Apollo Alternative Assets 1 17
Apple 5 315
Arcadis 251 8.623
Arcelor Mittal 2.024 318.658
Archos 1 1
Arcona Property Fund 1 267
arGEN-X 15 9.112
Aroundtown SA 1 176
Arrowhead Research 5 9.283
Ascencio 1 20
ASIT biotech 2 697
ASMI 4.107 37.695
ASML 1.762 77.029
ASR Nederland 18 4.122
ATAI Life Sciences 1 7
Atenor Group 1 333
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 29 10.663
Axsome Therapeutics 1 177
Azelis Group 1 49
Azerion 7 2.681

Macro & Bedrijfsagenda

  1. 03 mei

    1. Chinese beurzen gesloten ivm Labor Day
    2. Aperam Q1-cijfers
    3. Bpost Q1-cijfers
    4. Credit Agricole Q1-cijfers
    5. Ontex -Q1-cijfers
    6. Brunel Q1-cijfers
    7. Heijmans €0,89 ex-dividend
    8. VS banengroei en werkloosheid april Banengroei: 243K. Werkloosheid: 3,8%. Uurlonen: +0,3% MoM volitaliteit verwacht
    9. VS inkoopmanagersindex diensten S&P april (def)
    10. VS Inkoopmanagersindex diensten ISM april (def)
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht